BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】BioMotiv LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11192)・商品コード:DATA904C11192
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pigmentosa, anti-inflammatory, inflammatory diseases, chronic obstructive pulmonary disease, immuno-oncology and acute kidney injury, among others. BioMotiv serves inventors, investors, patients and physicians, among others. The company partners with harrington discovery institute, universities and research institutions, disease foundations, and industry sources. It offers research and development, and pre clinical services. BioMotiv is headquartered in Cleveland, Ohio, the US.

BioMotiv LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioMotiv LLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
BioMotiv Raises Additional USD1 Million in Venture Financing 20
Partnerships 21
Charles River Labs Enters into Agreement with BioMotiv 21
BioMotiv Forms Joint Venture with Rutgers University 22
BioMotiv Expands its Agreement with Biogen 23
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 24
Licensing Agreements 25
BioAtla Enters Into Licensing Agreement With BioMotiv 25
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 26
Equity Offering 27
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 27
Charles River Labs to Invest USD10 Million in BioMotiv 28
Acquisition 29
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 29
BioMotiv LLC – Key Competitors 30
BioMotiv LLC – Key Employees 31
BioMotiv LLC – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 34
Strategy And Business Planning 34
Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
BioMotiv LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Allinaire Therapeutics Raises Funds in Seed Financing 12
Allinaire Therapeutics Raises USD1 Million in Venture financing 13
BioMotiv Raises Additional USD30.5 Million in Venture Financing 14
BioMotiv Raises Additional USD4.8 Million in Venture Financing 15
Orca Pharma Raises USD1.3 Million in Venture Financing 16
Orca Pharma Raises Funds through Venture Financing 17
BioMotiv Raises US$25 Million In Venture Financing 18
BioMotiv Raises US$21 Million In Series A Financing 19
BioMotiv Raises Additional USD1 Million in Venture Financing 20
Charles River Labs Enters into Agreement with BioMotiv 21
BioMotiv Forms Joint Venture with Rutgers University 22
BioMotiv Expands its Agreement with Biogen 23
BioMotiv, University of California San Francisco and University of Washington Center for Commercialization Form Joint Venture 24
BioAtla Enters Into Licensing Agreement With BioMotiv 25
Sujana Biotech Enters into Licensing Agreement with Case Western Reserve University 26
BioMotiv to Raise up to USD25 Million in Private Placement of Shares 27
Charles River Labs to Invest USD10 Million in BioMotiv 28
Takeda Pharma Acquires Minority Stake in BioMotiv for USD25 Million 29
BioMotiv LLC, Key Competitors 30
BioMotiv LLC, Key Employees 31
BioMotiv LLC, Other Locations 32
BioMotiv LLC, Subsidiaries 32
BioMotiv LLC, Joint Venture 33

List of Figures
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioMotiv LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioMotiv LLC, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C11192)販売に関する免責事項を必ずご確認ください。
★調査レポート[BioMotiv LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆